| Report ID | 282788 |
| Drug Identification Number | 02552892 |
| Brand name | NAT-SUNITINIB |
| Common or Proper name | SUNITINIB |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUNITINIB |
| Strength(s) | 12.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 28 BLISTER AND BOTTLE |
| ATC code | L01EX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-04-13 |
| Actual start date | 2026-04-13 |
| Estimated end date | 2026-05-31 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-13 | French | Compare |
| v1 | 2026-04-13 | English | Compare |
Showing 1 to 2 of 2